CONFERENCE COVERAGE
Consortium of Multiple Sclerosis Centers
Annual Meeting
2018 COVERAGE
- Gait in MS Improved With Dalfampridine Plus Physical Therapy
- Medical Cannabis Promising for Improvement of MS-Related Symptoms
- MS Pain Common Disruptive Factor in Everyday Activities
- Dimethyl Fumarate Not Associated With Greater Pain vs Other DMTs in RRMS
- Skin Tone, Race May Be Associated With Multiple Sclerosis Diagnosis
- Proposed Protocol Taps Occupational Therapist for Assistance With MS Medication Adherence
- Optimized Urinalysis Reflex Reduces Urine Culture Orders in MS
- Certain Comorbidities More Common in People With Multiple Sclerosis
- Screening for TB Prior to Immunosuppressive Therapy Beneficial in MS
- Ozanimod Superior to Interferon for Relapsing Multiple Sclerosis
- Ocrelizumab May Improve Cognition in Patients At Risk for Progressive Multiple Sclerosis
- Alemtuzumab Reduces MRI Disease Activity, Brain Volume Loss in Relapsing-Remitting MS
Latest Tweets
Follow
@NeuroAdvisor
Conference Coverage from
